Nkmax Co., Ltd.
Overview
Nkmax Co., Ltd. is a South Korean biotechnology company that focuses on the development and commercialization of immunotherapeutic products. The company specializes primarily in natural killer (NK) cell therapies and aims to harness the power of the immune system to treat various diseases, including cancer.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Nkmax Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Nkmax Co., Ltd.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.